Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. - Wikidata - awgldk - TriplyDB

Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.

Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.

http://www.wikidata.org/entity/Q37083055

about

Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis An unexpected tail of VEGF and PlGF in pre-eclampsia Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms.Therapeutic potential of manipulating VEGF splice isoforms in oncology The anti-angiogenic isoforms of VEGF in health and disease.The role of VEGF-A165b in trophoblast survival.Molecular diversity of VEGF-A as a regulator of its biological activity.The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy The role of VEGF 165b in pathophysiology VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature.Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.Regulation of vascular function on posttranscriptional level.Pharmacology of Modulators of Alternative Splicing.Effects of exogenous VEGF(165)b on invasion and migration of human lung adenocarcinoma A549 cells.Mechanisms regulating angiogenesis underlie seasonal control of pituitary function.Systems Pharmacology of VEGF165b in Peripheral Artery Disease.Human chronic gonadotropin concentrations in very early pregnancy and subsequent preeclampsia.An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preecl Impaired vascular permeability regulation caused by the VEGF₁₆₅b splice variant in pre-eclampsia.Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.Role of vitamin D in up-regulating VEGF and reducing the risk of pre-eclampsia

P2860

Q26781355-E4C4BFA6-EE8F-4BBA-9E85-ABC2FAFECFC2 Q26825271-C6B00F2F-A35A-488C-9A10-8B592C5A7B11 Q27000996-3DE38229-D5B7-4411-8E06-092E12AE448C Q33557423-4DBD41CB-1370-4085-AC94-51A23F352730 Q33888458-8CA4C42B-EE02-489F-8E44-9096614C03CE Q33901839-E2F4875B-446E-45EE-9E23-1B60B221F8A3 Q34084917-F78FA761-1F8F-4458-AC28-9C6548E64D2B Q34089123-D1EB142E-8155-4FDE-9930-0C8DCD2920BA Q34792239-AF6E8DD1-CCA6-482D-8160-4C78B556F720 Q36542093-5EFF866B-2732-4097-8CD7-573779E63677 Q37400534-A113C860-EBD0-4C8F-8B7E-43DB41D45873 Q37748773-CB049A22-8923-4C44-B2FF-5072168AAC49 Q37935034-2F531C5B-C3CC-4EB8-A420-C7216B2883E2 Q38167316-19227A87-342D-42C5-A503-0EEDD9B5856A Q38776406-2F83FB12-20E7-4AD1-8C0C-426407607C00 Q39450742-94DD6CCA-874A-4912-8020-2ED95D37B1E2 Q41710010-B154E43E-C076-4443-9855-A5C58D45600E Q45074473-8CFC207D-0BDD-4EE6-AC78-30DC708EA3D7 Q47211715-17C69482-9E28-4E8C-9AAB-F359DD714F62 Q47680120-8A49FBD6-C4AE-449D-AD23-10CEC7062E22 Q54582363-A6967CA0-4E7B-4781-9DA5-17FB1EC44E73 Q55343200-6A869288-D00B-41AD-91F0-210153EB9BB2 Q57200588-D8D16F68-7E12-4A62-8736-8FC70804E62D

P2860

Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.

http://www.wikidata.org/entity/Q37083055

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@en

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@nl

type

label

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@en

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@nl

prefLabel

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@en

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@nl

P1433

Q37083055-1C9F5C42-4557-492A-8B91-6C7B21152824

P1476

Q37083055-73C33549-2576-41E3-9E32-A23A34CB5EED

P2093

Q37083055-143DC1E7-9E9C-4E54-B841-C349A0BEECCE

Q37083055-5980A2C2-9384-4845-98DD-59824CDA70B2

Q37083055-6D4CC3C3-1457-4EAA-AB7A-FFB0EA5711AA

Q37083055-8EC28DC9-EA52-4058-ABCD-0B8162AD72B2

Q37083055-B2C15256-DF06-4196-927A-C4778999AFC2

P2860

Q37083055-07019092-9304-441E-9307-FE652F1940D4

Q37083055-07D160B5-F316-4BFC-8800-1D73CF65ECD5

Q37083055-19D634F0-F3E4-497A-BED5-754AB7D5496F

Q37083055-2383EE5C-16F7-4B2E-B1ED-B5873BB44918

Q37083055-41437267-240D-40F0-AA4F-BF278E2984A0

Q37083055-4A99CCC9-0459-462E-B4B7-A6976752E973

Q37083055-4DEF941A-998E-4870-8CD3-59F00E09824B

Q37083055-5DA78119-103D-4961-854A-9AF9C717837B

Q37083055-631DE629-C02E-47F6-BE72-081965D2B0C1

Q37083055-697D7443-AE43-47D7-B1EB-F014E1BE1B1B

P304

Q37083055-00251639-971A-4FCF-8E54-5396B4D0DE5C

P31

Q37083055-793F1901-0A56-4B2F-AE01-8DD2EB6E693F

P356

Q37083055-23B6BC89-FC3C-40F4-95A6-1F287638FB49

P407

Q37083055-AD1A374F-EFF5-4AF2-ACFB-D27D9E510836

P433

Q37083055-FF910F47-0F03-4B10-BE64-A785780B3190

P478

Q37083055-6E5D3369-89DF-4CB1-BA0A-EF5366384BC0

P50

Q37083055-868870BC-FF7C-403E-AFE0-91BA00811F8D

P577

Q37083055-8098B503-5398-4AE1-BC0A-FD667DA7A45A

P698

Q37083055-DF5234CA-9AFC-4DF1-A08A-E1E6F3AC619A

P921

Q37083055-40978092-9910-4FCD-BBD1-5FA8D7DB62B0

P932

Q37083055-C64FDD6A-1F19-45A5-B921-E7D60B0CE1AC

P356

P1433

Clinical Science

P1476

Failure to up-regulate VEGF165 ...... tive marker for pre-eclampsia.

@en

P2093

Ann Millar

http://www.w3.org/2001/XMLSchema#string

Julia Varet

http://www.w3.org/2001/XMLSchema#string

Peter W Soothill

http://www.w3.org/2001/XMLSchema#string

Steven J Harper

http://www.w3.org/2001/XMLSchema#string

Victoria L Bills

http://www.w3.org/2001/XMLSchema#string

P2860

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

Soluble endoglin contributes to the pathogenesis of preeclampsia

Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia

WHO analysis of causes of maternal death: a systematic review

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Vascular endothelial growth factor: basic science and clinical progress.

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.

The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia.

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.

P304

265-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20080270

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18826376

http://www.w3.org/2001/XMLSchema#string

P921

P932

2635543

http://www.w3.org/2001/XMLSchema#string